איומרון 300
Country: Iżrael
Lingwa: Ebrajk
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
IOMEPROL
Disponibbli minn:
DEXCEL LTD, ISRAEL
Kodiċi ATC:
V08AB10
Għamla farmaċewtika:
תמיסה להזרקה
Kompożizzjoni:
IOMEPROL 612.4 MG/ML
Rotta amministrattiva:
תוך-ורידי, תוך-עורקי
Tip ta 'preskrizzjoni:
מרשם נדרש
Manifatturat minn:
BRACCO IMAGING S.P.A., ITALY
Grupp terapewtiku:
IOMEPROL
Żona terapewtika:
IOMEPROL
Indikazzjonijiet terapewtiċi:
Contrast medium for diagnostic radiology. Intravenous urography ( in adults and paediatrics), peripheral phlebography, CT (brain and body), cavernosography, intravenous DSA, conventional angiography, intraarterial DSA, angiocardiography (in adults and paediatrics), conventional selective coronary arteriography, interventional coronary arteriography, ERCP, arthrography, hysterosalpingography, fistulography, discography, galactography, chloangiography, dacryocystography, sialography, retrograde urethrography, retrograde pyelo-ureterography.
Data ta 'l-awtorizzazzjoni:
2021-12-31
